RhumbLine Advisers’s Janux Therapeutics JANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.37M Buy
2025
Q1
$1.15M Buy
2024
Q4
$2.04M Buy
2024
Q3
$1.71M Sell
2024
Q2
$1.59M Buy
2024
Q1
$1.01M Buy
2023
Q4
$280K Sell
2023
Q3
$267K Sell
2023
Q2
$318K Sell
2023
Q1
$325K Buy
2022
Q4
$338K Buy
2022
Q3
$346K Buy
2022
Q2
$292K Buy
2022
Q1
$233K Buy
2021
Q4
$218K Sell
2021
Q3
$240K Buy